Trial Condition(s):
Julina post-marketing surveillance for climacteric symptoms in Japan (JULINA-CLIMA)
15073
Not Available
Not Available
This study is a regulatory post-marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received Julina for postmenopausal osteoporosis. The objective of this study is to assess safety and efficacy of using Julina in clinical practice. A total 100 patients will be recruited and followed 3 years since starting Julina administration.
- Patients who received Julina for postmenopausal osteoporosis
- Patients who are contraindicated based on the product label
Locations | |
---|---|
Locations Investigative Site Many Locations, Japan | Contact Us: E-mail: [email protected] Phone: Not Available |
Drug use investigation of Julina Tablets 0.5 mg (postmenopausal osteoporosis)
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1